| Literature DB >> 25496447 |
Yi-Da Wang, Shin-Jie Huang, Hong-Nong Chou, Wen-Liang Liao, Hong-Yi Gong, Jyh-Yih Chen1.
Abstract
BACKGROUND: Orange-spotted grouper (Epinephelus coioides) with protogynous hermaphroditic features are one of the most economically important aquaculture species in Taiwan. However, larvae stage grouper are susceptible to infection by the bacterial pathogen Vibrio alginolyticus. To better understand the molecular mechanisms of the immune response to V. alginolyticus in Epinephelus coioides larvae, we used high-throughput deep sequencing technology to study the effect of infection on gene expression.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25496447 PMCID: PMC4407539 DOI: 10.1186/1471-2164-15-1102
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Summary of larvae transcriptome assembly
| Transcriptome sequences | |
|---|---|
| Total Reads | 114,851,002 |
| Total Nucleotides (nt) | 9,687,355,560 |
| Total Contig Number | 209,082 |
| Mean Length of Contig (bp) | 372 |
| Total Contig Length (nt) | 77,845,532 |
| Total Unigene Number | 116,678 |
| Mean Length of Unigene (bp) | 685 |
| Total Length of all Unigene (nt) | 79,966,605 |
| Genes in NR database | 53518 |
| Genes in NT database | 64066 |
| Genes in SwissProt database | 46315 |
| Genes in KEGG database | 37075 |
| Genes in COG database | 14422 |
| Genes in GO database | 18252 |
| Genes in all databases | 69334 |
Figure 1Comparison of unigene expression as Reads Per kb per Million (RPKM). Expression level was determined using the RPKM method, thereby eliminating the influences of gene length and sequencing discrepancies on the calculation of gene expression. , RPKM with 102,857 unigenes, , RPKM after selection based on FDR ≤ 0.001 AND |log2Ratio| ≥ 1with 3,977 unigenes. Va-24 hr: RPKM at 24 hours after infection with V. alginolyticus, TSB (tryptic soy broth)-24 hr: RPKM at 24 hours after injection with TSB.
Gene ontology analysis of larvae
|
| |||
| Gene Ontology term | Cluster frequency | Genome frequency of use | Corrected P-value |
| Myosin complex | 45 out of 1129 genes, 4.0% | 162 out of 28794 genes, 0.6% | 1.46E-23 |
| Actin cytoskeleton | 79 out of 1129 genes, 7.0% | 656 out of 28794 genes, 2.3% | 1.62E-16 |
| Contractile fiber | 59 out of 1129 genes, 5.2% | 501 out of 28794 genes, 1.7% | 1.28E-11 |
| Extracellular region | 106 out of 1129 genes, 9.4% | 1483 out of 28794 genes, 5.2% | 3.55E-07 |
| Myofibril | 43 out of 1129 genes, 3.8% | 433 out of 28794 genes, 1.5% | 6.02E-06 |
| Sarcomere | 36 out of 1129 genes, 3.2% | 327 out of 28794 genes, 1.1% | 6.05E-06 |
| Contractile fiber part | 36 out of 1129 genes, 3.2% | 332 out of 28794 genes, 1.2% | 8.94E-06 |
| Cytoskeleton | 173 out of 1129 genes, 15.3% | 3012 out of 28794 genes, 10.5% | 3.39E-05 |
| Extracellular region part | 92 out of 1129 genes, 8.1% | 1346 out of 28794 genes, 4.7% | 3.53E-05 |
| Striated muscle thin filament | 9 out of 1129 genes, 0.8% | 25 out of 28794 genes, 0.1% | 5.28E-05 |
|
| |||
| Hydrolase activity | 283 out of 1138 genes, 24.9% | 5158 out of 28380 genes, 18.2% | 2.08E-06 |
| Cytoskeletal protein binding | 101 out of 1138 genes, 8.9% | 1398 out of 28380 genes, 4.9% | 2.80E-06 |
| Hydrolase activity, acting on acid anhydrides | 132 out of 1138 genes, 11.6% | 2114 out of 28380 genes, 7.4% | 8.62E-05 |
| Pyrophosphatase activity | 131 out of 1138 genes, 11.5% | 2097 out of 28380 genes, 7.4% | 9.39E-05 |
|
| |||
| Lucose metabolic process | 42 out of 1105 genes, 3.8% | 279 out of 27537 genes, 1.0% | 2.39E-10 |
| Hexose metabolic process | 48 out of 1105 genes, 4.3% | 443 out of 27537 genes, 1.6% | 7.72E-07 |
| Muscle system process | 52 out of 1105 genes, 4.7% | 520 out of 27537 genes, 1.9% | 2.54E-06 |
| Small molecule metabolic process | 215 out of 1105 genes, 19.5% | 3657 out of 27537 genes, 13.3% | 4.39E-06 |
| Protein activation cascade | 11 out of 1105 genes, 1.0% | 31 out of 27537 genes, 0.1% | 2.49E-05 |
| Monosaccharide metabolic process | 48 out of 1105 genes, 4.3% | 493 out of 27537 genes, 1.8% | 2.50E-05 |
| Muscle contraction | 37 out of 1105 genes, 3.3% | 328 out of 27537 genes, 1.2% | 2.55E-05 |
| Complement activation | 9 out of 1105 genes, 0.8% | 20 out of 27537 genes, 0.1% | 4.39E-05 |
| Alcohol metabolic process | 69 out of 1105 genes, 6.2% | 854 out of 27537 genes, 3.1% | 4.72E-05 |
KEGG pathway enrichment analysis of larvae
| List | KEGG pathway | NGS with pathway annotation (1504) | All genes with pathway annotation (32664) | P-value | Q-value | Pathway ID |
|---|---|---|---|---|---|---|
|
| ||||||
|
| ||||||
|
| Glycolysis/Gluconeogenesis | 25 (1.66%) | 173 (0.53%) | 4.10E-07 | 7.42E-06 | ko00010 |
|
| Starch and sucrose metabolism | 21 (1.4%) | 167 (0.51%) | 2.98E-05 | 3.59E-04 | ko00500 |
|
| ||||||
|
| ||||||
|
| Tight junction | 112 (7.45%) | 1224 (3.75%) | 3.60E-12 | 8.68E-11 | ko04530 |
|
| ||||||
|
| Phagosome | 55 (3.66%) | 651 (1.99%) | 1.27E-05 | 1.84E-04 | ko04145 |
|
| ||||||
|
| Regulation of actin cytoskeleton | 98 (6.52%) | 1387 (4.25%) | 1.81E-05 | 2.45E-04 | ko04810 |
|
| ||||||
|
| ||||||
|
| Cardiac muscle contraction | 108 (7.18%) | 742 (2.27%) | 1.81E-26 | 3.94E-24 | ko04260 |
|
| Vascular smooth muscle contraction | 88 (5.85%) | 988 (3.02%) | 2.97E-09 | 5.86E-08 | ko04270 |
|
| ||||||
|
| Protein digestion and absorption | 91 (6.05%) | 575 (1.76%) | 4.50E-25 | 4.88E-23 | ko04974 |
|
| Pancreatic secretion | 70 (4.65%) | 618 (1.89%) | 4.61E-12 | 1.00E-10 | ko04972 |
|
| ||||||
|
| Complement and coagulation cascades | 60 (3.99%) | 341 (1.04%) | 3.13E-19 | 1.36E-17 | ko04610 |
|
| Antigen processing and presentation | 20 (1.33%) | 152 (0.47%) | 2.36E-05 | 3.01E-04 | ko04612 |
|
| ||||||
|
| ||||||
|
| Staphylococcus aureus infection | 44 (2.93%) | 206 (0.63%) | 1.00E-17 | 3.62E-16 | ko05150 |
Figure 2Colony-Forming Units (CFUs) in larvae infected with . Larvae were injected with 1.3 × 106 CFU/ml V. alginolyticus (20 μl per fish). Control fish were injected with Tryptic soy broth containing 1.5% NaCl. Significance was set at P < 0.05, as determined by one-way ANOVA followed by Duncan’s test.
Figure 3Complement-related pathway gene expression in controls and grouper challenged with 1.3 × 10 CFU/ml (20 μl/fish) , as determined by qRT-PCR. ( ) A2M, ( ) BF, ( ) CR2, ( ) C1q, ( ) C1r, ( ) C1s, ( ) C3, ( ) C4, ( ) C4BP, ( ) C5, ( ) C6, and ( ) C6-d. Values are presented as the mean ± SEM (n = 5). Values with different letters differ significantly. Significance was set at P < 0.05, as determined by one-way ANOVA followed by Duncan’s test.
Figure 4Complement-related pathway gene expression in controls and grouper challenged with 1.3 × 10 CFU/ml (20 μl/fish) , as determined by qRT-PCR. ( ) C7, ( ) C8, ( ) C8-d, ( ) C9, ( ) DAF, ( ) MASP1/2, ( ) HF, ( ) IF ( ) PLG, and ( ) SERPING1. Values are presented as the mean ± SEM (n = 5). Values with different letters differ significantly. Significance was set at P < 0.05, as determined by one-way ANOVA followed by Duncan’s test.
Figure 5Phagocytosis-related pathway gene expression in controls and grouper challenged with 1.3 × 10 CFU/ml (20 μl/fish) , as determined by qRT-PCR. ( ) αVβ3, ( ) αVβ3-2, ( ) αVβ5, ( ) Calnexin, ( ) Cathepsin, ( ) Collectins, ( ) DCSIGN, ( ) DCSIGN2, ( ) Dynein, ( ) EEA1, ( ) F-actin, and ( ) F-actin-d. Values with different letters differ significantly. Values are presented as the mean ± SEM (n = 5). Significance was set at P < 0.05, as determined by one-way ANOVA followed by Duncan’s test.
Figure 6Phagocytosis-related gene expression in controls and grouper challenged with 1.3 × 10 CFU/ml (20 μl/fish) , as determined by qRT-PCR. ( ) HSP70, ( ) Ii-d, ( ) LAMP, ( ) MHCI, ( ) MHCII, ( ) MPO-d, ( ) MR, ( ) MR-d, ( ) NFY, ( ) TAPBP, ( ) TfR, and ( ) TUBB Values are presented as the mean ± SEM (n = 5). Values with different letters differ significantly. Significance was set at P < 0.05, as determined by one-way ANOVA followed by Duncan’s test.
Figure 7Antimicrobial peptide gene expression in control and grouper challenged with 1.3 × 10 CFU/ml (20 μl/fish) , as determined by qRT-PCR. ( ) Hepcidin, ( ) LAP2, and ( ) Piscidin. Values are presented as the mean ± SEM (n = 5). Values with different letters differ significantly. Significance was set at P < 0.05, as determined by one-way ANOVA followed by Duncan’s test.
Figure 8Predicted model of the immune response of larvae to infection. The times (in h) besides each gene indicate the time post-V. alginolyticus infection at which its expression is significantly increased (red font indicates uncertainty). The classical pathway involves (i) cleavage of C4 to C3 convertase by C1s, (ii) cleavage of C3 to C3b by C3 convertase, (iii) combination of C3b with C5, (iv) cleavage of the resulting complex to C5b by C5 convertase, and (v) formation of the membrane attack complex (MAC) and lysis of V. alginolyticus. The lectin pathway involves C-type lectin-mediated cleavage of C4 and C2 by MASP1/2, and subsequent cleavage of C3 by C3 convertase. The alternative pathway involves cleavage of C3 by factor B; like the classical pathway, factor I acts as an inhibitor in the alternative pathway. Hepcidin may directly kill the bacterium by disrupting its membrane.